Alrex (Loteprednol Etabonate Ophthalmic) - Indications and Dosage

INDICATIONS AND USAGE

ALREX Ophthalmic Suspension is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis.

DOSAGE AND ADMINISTRATION

SHAKE VIGOROUSLY BEFORE USING.

One drop instilled into the affected eye(s) four times daily.

HOW SUPPLIED

ALREX® (loteprednol etabonate ophthalmic suspension, 0.2%) is supplied in a plastic bottle with a controlled drop tip in the following sizes:

5 mL (NDC 24208-353-05) - AB35307

10 mL (NDC 24208-353-10) - AB35309

DO NOT USE IF NECKBAND IMPRINTED WITH "Protective Seal" AND YELLOW IS NOT INTACT.

STORAGE

Store upright between 15°–25°C (59°–77°F). DO NOT FREEZE.

KEEP OUT OF REACH OF CHILDREN.

Revised April 2006

MANUFACTURER INFORMATION

Bausch & Lomb Incorporated, Tampa, Florida 33637

U.S. Patent No. 4,996,335
U.S. Patent No. 5,540,930
U.S. Patent No. 5,747,061

©Bausch & Lomb Incorporated
Alrex® is a registered trademark of Bausch & Lomb Incorporated

9007901 (Folded)
9005501 (Flat)